Chronic ataxic neuropathy with cold agglutinins
Atypical phenotype and response to anti-CD20 antibodies
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
A syndrome of sensory ataxia has been associated with immunoglobulin (Ig) M antibodies to NeuNAc (alpha2–8), NeuNAc (alpha2–3), and disialylated gangliosides, including GD1b, GD3, GD2, GT1a, GT1b, and GQ1b.1-3⇓⇓ In some patients, cold agglutinins have also been present.4 The acronym CANOMAD encompasses the clinical phenotype of chronic ataxic neuropathy with ophthalmoplegia, M-protein, agglutination, and antidisialosyl antibodies.1,4⇓ This condition is distinguished from the Miller Fisher variant of Guillain–Barre syndrome by the presence of cold agglutinins and occasionally cryoglobulins and by the chronic and progressive nature of the phenotype.
Case report.
A 53-year-old man developed slowly progressive unsteadiness and painful paraesthesias in his extremities during a 5-month period. His examination revealed marked gait disturbance, sensory ataxia, and weakness in the distal extremities. The remainder of his neurologic examination was normal. Lumbar puncture yielded an elevated CSF protein (85 mg%). Neurophysiologic studies revealed temporal dispersion and prolonged distal latencies that were more marked in the sensory nerves than in the motor nerves. Denervation activity was …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Brief Communications
Sustained remission of CIDP associated with Evans syndromeHans Knecht, Michael Baumberger, Aurelio Tobòn et al.Neurology, August 23, 2004 -
Article
Chronic inflammatory demyelinating polyneuropathyClinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathyKenneth C. Gorson, Gregory Allam, Allan H. Ropper et al.Neurology, February 01, 1997 -
Views & Reviews
The Wide Spectrum of Pathophysiologic Mechanisms of Paraproteinemic NeuropathyJean-Michel Vallat, Mathilde Duchesne, Philippe Corcia et al.Neurology, December 04, 2020 -
BRIEF COMMUNICATIONS
Chronic inflammatory demyelinating polyneuropathy associated with malignant melanomaShawn J. Bird, Mark J. Brown, Michael E. Shy et al.Neurology, March 01, 1996